組織蛋白酶L(CTSL)多克隆抗體
Polyclonal Antibody to Cathepsin L (CTSL)
CTSL1; CATL; CTS-L; MEP; Cathepsin L1; Major excreted protein
- 編號PAA306Mu01
- 物種Mus musculus (Mouse，小鼠) 相同的名稱，不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 免疫原 RPA306Mu01-組織蛋白酶L(CTSL)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性狀液體
- 濃度1mg/ml
- 且適物種Rattus norvegicus (Rat，大鼠)
- 應(yīng)用WB; IHC; ICC; IP.
如果抗體需用于流式細胞術(shù)，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 583 ¥ 1361 ¥ 1944 ¥ 4860 ¥ 19440
- 欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
DAB staining on IHC-P; Samples: Mouse Cerebrum Tissue; Primary Ab: 20μg/ml Rabbit Anti-Mouse CTSL Antibody Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody (Catalog: SAA544Rb19)
-
DAB staining on IHC-P;
Samples: Mouse Cerebrum Tissue
-
Figure. Western Blot; Sample: Recombinant CTSL, Mouse.
-
通過ISO 9001、ISO 13485質(zhì)量體系認證
特異性
該抗體是針對CTSL的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別CTSL。
用法
Western blotting: 0.5-2μg/mL;1:500-2000
Immunohistochemistry: 5-20μg/mL;1:50-200
Immunocytochemistry: 5-20μg/mL;1:50-200
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Mus musculus (Mouse，小鼠) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPA306Mu01 | 組織蛋白酶L(CTSL)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA306Mu02 | 組織蛋白酶L(CTSL)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA306Mu02 | 組織蛋白酶L(CTSL)多克隆抗體 | WB; IHC; ICC; IP. |
| PAA306Mu01 | 組織蛋白酶L(CTSL)多克隆抗體 | WB; IHC; ICC; IP. |
| LAA306Mu71 | 組織蛋白酶L(CTSL)多克隆抗體(生物素標記) | WB; IHC; ICC. |
| SEA306Mu | 組織蛋白酶L(CTSL)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA306Mu | 組織蛋白酶L(CTSL)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| Hypertension | Identification of Cathepsin L as a Potential Sex-Specific Biomarker for Renal Damage. [Ahajournals: source] |
| The Journal of International Medical Research | Plasma Cathepsin L and Its Related Pro/Antiangiogenic Factors Play Useful Roles in Predicting Rich Coronary Collaterals in Patients with Coronary Heart Disease [Ingenta: art00021] |
| Atherosclerosis.? | Biochemical and clinical correlation of intraplaque neovascularization using contrast-enhanced ultrasound of the carotid artery [Pubmed:24534452] |
| International Journal of Molecular Sciences | A New Analytical Method for Determination of Cathepsin L Based on the Surface Plasmon Resonance Imaging Biosensor [Pubmed: 31052424] |
| EMBO Molecular Medicine | Immune‐mediated ECM depletion improves tumour perfusion and payload delivery [Pubmed: 31709774] |
| Cardiovasc Res | Inhibition of myocardial cathepsin-L release during reperfusion following myocardial infarction improves cardiac function and reduces infarct size [34132807] |
留言咨詢
